在接种COVID-19疫苗后,出现焦虑症和失眠的风险
Haerin Cho1, Joon Hyung Jung2, Hwoyeon Seo3
1Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea.
Journal of psychiatric research
|October 25, 2025
概括
接种COVID-19疫苗与更高的焦虑症和失眠风险有关. 这项研究强调了接种疫苗后潜在的心理健康考虑因素,需要与其他流行病相关因素一起仔细解释.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 心理健康研究 心理健康研究
背景情况:
- 关于COVID-19疫苗不良事件的广泛研究存在,但心理健康影响仍然被低估.
- 了解疫苗接种后的心理健康结果对于公共卫生战略至关重要.
研究的目的:
- 评估在韩国接种COVID-19疫苗后出现焦虑障碍和失眠的风险.
- 量化COVID-19疫苗接种与特定心理健康状况之间的关联.
主要方法:
- 采用了一种自我控制的案例系列研究设计.
- 利用了COVID-19疫苗注册和国家健康保险服务索赔数据.
- 分析了2021年2月至9月期间接种疫苗的18岁以上个体的数据.
主要成果:
- 在所有疫苗接种后的风险间隔中观察到焦虑症风险增加.
- 在大多数时间间隔中,失眠风险较高,除了接种疫苗后的前7天.
- 该研究发现了大量的焦虑 (156,290) 和失眠 (250,704) 病例.
结论:
- 接种COVID-19疫苗与焦虑症和失眠的风险增加有关.
- 由于流行病压力和寻求医疗保健的行为变化等混因素,研究结果需要谨慎解释.
- 可能需要进一步的研究来阐明疫苗接种和心理健康之间的复杂关系.
相关概念视频
Insomnia
400
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
400
Anxiety: Overview
896
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
896
Insufficient Sleep and Sleep Deprivation
828
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
828
Management of Insomnia
528
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
528
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K


